Randomised, prospective multicentre clinical study on the effect of the combination of lopinavir/rtv [lopinavir/ritonavir; Kaletra] + nevirapine as maintenance bitherapy (without nucleoside analogues) in comparison with a triple therapy including lopinavir/rtv + nucleoside analogues in HIV-infected patients.

Trial Profile

Randomised, prospective multicentre clinical study on the effect of the combination of lopinavir/rtv [lopinavir/ritonavir; Kaletra] + nevirapine as maintenance bitherapy (without nucleoside analogues) in comparison with a triple therapy including lopinavir/rtv + nucleoside analogues in HIV-infected patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Jan 2010

At a glance

  • Drugs Lopinavir/ritonavir; Nevirapine; Nucleoside reverse transcriptase inhibitors
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms MULTINEKA
  • Most Recent Events

    • 15 Sep 2009 Results published in Clinical Infectious Diseases.
    • 05 Jun 2007 Status change from in progress to completed.
    • 08 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top